Cargando…
Targeting MYCN in Molecularly Defined Malignant Brain Tumors
Misregulation of MYC genes, causing MYC overexpression or protein stabilization, is frequently found in malignant brain tumors highlighting their important roles as oncogenes. Brain tumors in children are the most lethal of all pediatric malignancies and the most common malignant primary adult brain...
Autores principales: | Borgenvik, Anna, Čančer, Matko, Hutter, Sonja, Swartling, Fredrik J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877538/ https://www.ncbi.nlm.nih.gov/pubmed/33585252 http://dx.doi.org/10.3389/fonc.2020.626751 |
Ejemplares similares
-
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
por: Mainwaring, Oliver J., et al.
Publicado: (2023) -
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells
por: Čančer, Matko, et al.
Publicado: (2019) -
Modeling and Targeting MYC Genes in Childhood Brain Tumors
por: Hutter, Sonja, et al.
Publicado: (2017) -
Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors
por: Suenaga, Yusuke, et al.
Publicado: (2021) -
Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy
por: Čančer, Matko, et al.
Publicado: (2019)